difference in side effects between semaglutide and tirzepatide Why You Might Tolerate One Weight Loss Drug Better Than Another Semaglutide vs. Tirzepatide: Similarities and

36.2 million people with ESI are potentially eligible for GLP-1 drugs based on an obesity diagnosis alone

Explore other treatments with a healthcare professional if you have this condition

Potential downsides However, there are important trade-offs: * Efficacy: Staying indefinitely on very low doses (below 5 mg) may deliver less weight loss than seen in the trials that inform NICE guidance and national policy

Allulose, a rare sugar with minimal calories, has gained attention for its potential to stimulate glucagon-like peptide-1 (GLP-1), an incretin hormone crucial for blood sugar regulation and appetite control

For many people, the health benefits of weight loss far outweigh the small risk of serious side effects